News
The pandemic experience through the eyes of APPs
November 20, 2020
The need for advanced practice providers has led to an evolving integration between physicians and APPs.
News
Pfizer’s COVID-19 vaccine 95% effective in final phase 3 results
November 19, 2020
The vaccine was well tolerated with no serious safety concerns.
News
‘Hospital at home’ increases COVID capacity in large study
November 18, 2020
Atrium Health developed a “hospital at home” program for COVID patients and brought it online in just 2 weeks.
News
Predicting patient risk of medication-related harm
November 18, 2020
Clinicians can calculate the risk of a patient suffering medication-related harm post-discharge.
News
Myocarditis rare, macrophage infiltration common at COVID autopsy
November 18, 2020
An autopsy study shows myocarditis is uncommon, seen in only 14% of COVID-19 deaths, but macrophage infiltration is very common and might explain cardiac imaging findings from earlier studies.
News
Liver injury linked to COVID-19–related coagulopathy
November 18, 2020
Cells that line the liver’s blood vessels produce high levels of factor VIII, a coagulation factor, when they are exposed to interleukin-6, an inflammatory molecule associated with COVID-19.
News
One-third of critical illness survivors emerge from ICU with functional deterioration
November 18, 2020
One-third of patients who survived nonsurgical ICU admission had evidence of functional status decline.
News
COVID-19 burdens follow patients after discharge
November 18, 2020
Postdischarge COVID-19 patients have high rates of long-term sequelae from sepsis and other severe respiratory viral illnesses.
News
Factor XI inhibitor–based anticoagulation strategies gain ground
November 18, 2020
“When we compare the FXI inhibitors with existing anticoagulants, we don’t necessarily want to go up against the DOACs.”
News
Metapneumovirus infections clinically indistinguishable from flu, RSV
November 17, 2020
Those at risk for severe or fatal metapneumovirus infections include frail elderly and patients with cardiovascular disease or compromised immunity.